Skip to main content

ACCELLIX™

CELLULAR QUALITY ASSESSMENT WITHOUT COMPLEXITY

Bringing the Power of Flow Cytometry to Cell Therapy Development & Manufacturing

Cell and gene therapy quality control is critical. It doesn’t have to be difficult. 

Stringent quality and process control is essential to monitor critical parameters, from cellular starting material collection through cell therapy manufacturing, and these laborious tests are challenging to standardize. The ACCELLIX™ Automated Cell Phenotyping Platform eliminates these limitations and automates your entire testing workflow, from sample preparation to data analysis, generating rapid cell phenotyping results directly in the collection site and/or manufacturing suite.

Overview

Fully Automated Flow Cytometry

With a partner-first approach to the pharmaceutical industry, bioMérieux joins forces with U.S. interdisciplinary group Accellix, manufacturer of the ACCELLIX™ system, to enable its partners in the field of cell therapy to meet their critical quality control requirements as they advance life-changing therapies benefiting patients worldwide.

The ACCELLIX™ platform delivers standardized insights into cell phenotype, enumeration, viability, identity and purity, helping to strengthen cellular starting material characterization while simplifying incoming, in process and release testing throughout the entire cell therapy manufacturing workflow.

Please accept targeting cookies to allow Youtube video

Cellular Quality Without Complexity

ACCELLIX™ is a streamlined flow cytometry system requiring only 2 minutes of hands-on time, delivering rapid and reliable cell attribute results with fully automated data analysis for blood starting materials and cell therapies—no cytometry expertise required. 
30 Minutes Total Assay Running Time

  

Explore the Benefits

ACCELLIX™ offers critical advantages for starting material characterization and cell therapy manufacturing:

  • Rapid time-to-result
  • Testing close to production line
  • Reduced labor costs
  • Minimized human error and subjectivity
The Accellix platform being worked on by a woman in a lab for automated flow cytometry.

Product Details

How It Works

ACCELLIX How It Works

Features

  • Small footprint bench-top platform
  • User friendly software 
  • Manufacturing suite compatible fan-less operation
  • 24/7 accessibility
  • Plug-&-play
  • Minimal maintenance and no calibration
  • 1 hour setup and operator training
  • Algorithm-based autoanalysis

ACCELLIX™ assays include a microfluidic cartridge with unitized dried-down reagents, enabling integrated and standardized sample preparation while improving reproducibility and accuracy by minimizing manual handling.

  • Room temperature stable dried down reagents
  • Compatible with various sample types and conditions
  • Wide sample concentration range
 
  • Minimal sample volume
  • No cross-contamination
  • Reduces workflow time by automating manual steps

Available Kits

  • T CELL SUBSET ASSAYS
    ACCELLIX™ T Cell Subset assays are used to enumerate common T Cell populations.
  • STEM CELL ASSAYS
    ACCELLIX™ Stem Cell assays are used to enumerate hematopoietic progenitor cells.
  • LYMPHOCYTE SUBSET ASSAYS
    ACCELLIX™ Lymphocyte Subset assays are used to enumerate T cell, Monocyte, B cell, and NK cell populations.
  • CUSTOMIZED ASSAYS
    We will work with your team to engineer customized assays tailored to your unique targets.

Support And Services Where And When You Need

Your productivity and product quality are our priority. At bioMérieux, we aren’t just selling fast and reliable solutions – our technical team and scientific experts are fully committed to help you get the most out of your equipment, to ensure the continuity of your operations.

Get in Touch to Discuss Customized Solutions
Please accept targeting cookies to allow Youtube video

Our dedicated teams are here to support you throughout your transformation. As your partner, we’re committed to providing you with the assistance and services you need at every step of your operations journey, from implementation to routine use.

Image Feasability Study

Feasibility Studies

We’ll prove the compatibility of your matrices with a validated bioMérieux platform depending on your microbiological specifications.

Learn More

Validation Protocols

We help you expedite the implementation of your investment by reducing validation time and expense.

Learn More

Supply Services

We help you minimize your administrative operations so you can focus on your core business activities.

Learn More

Maintenance Support

With the OPTIMAL Service Contract, you can maximize instrument uptime and ensure continuous operations by guiding your maintenance team to increase their efficiency in operational maintenance management of your instruments.

Learn More

Smart Remote Services

Through our Smart Remote solutions VILINK®, EASY ASSIST and SELF ASSIST, we’re able to fix most of your issues remotely and assist your laboratory specialists in achieving full autonomy.

Learn More

Access Useful Resources

If you are looking for a Certificate of Analysis (CoA) or Certificate of Quality (CoQ), you can access them from the Resource Center using your credentials. 

 

Want To Discuss Your Needs? 

Complete the form below to get in touch with our team. A bioMérieux expert will be in touch using the contact information you provide. By providing your information, you agree to receive additional emails from bioMérieux about cell and gene therapy quality control.

To find out more about the management of your personal data and to exercise your rights, see our privacy policy.

  

You May Also Like...

Comparative Evaluation of Automated and Conventional Flow Cytometry Methods for Leukapheresis Characterization Upon Cryopreservation Process

This poster compares the analytical performance of a conventional flow cytometry method with the automated ACCELLIX™ platform for the characterization of lymphocyte subpopulations in cryopreserved leukapheresis samples.

Learn More

Cell & Gene Therapy Solutions

Bring simplicity and automationg to Cell & Gene Therapy manufacturing through advanced technologies that enhance quality, safety and efficiency; to achieve faster product release.

Learn More

Concurrent Enumeration of CD34+ and CD3+ Cells in Allogeneic Apheresis Collections Using a New Flow Cytometry Method

We evaluated a new flow cytometry method that enables in-house simultaneous enumeration of CD34+ and CD3+ cells in a single assay with the potential to streamline graft characterization, reduce turnaround time, and decrease resource utilization.

Learn More